Acorda Therapeutics Stock Price - ACOR

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 2.04 ▲ 0.01 (0.49%)
Company Name Stock Ticker Symbol Market Type
Acorda Therapeutics Inc ACOR NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.04 -1.93% 2.03 2.10 2.00 2.08 2.07 23:59:37
Bid Price Ask Price Spread Spread % News
2.01 2.14 0.13 6.07% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,138 3,254,913 $ 2.03 $ 6,622,693 3,219,466 1.49 - 17.41
Last Trade Time Type Quantity Stock Price Currency
19:05:56 formt 250 $ 2.04 USD

Acorda Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 97.50M 48.03M $ 33.68M 0.71 - 46.89M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Acorda Therapeutics News

Loading Messages....

Latest ACOR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACOR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.482.571.8152.173,634,923-0.45-18.15%
1 Month1.802.781.7652.364,419,6590.2312.78%
3 Months1.962.781.492.152,545,7150.073.57%
6 Months6.897.131.492.652,076,263-4.86-70.54%
1 Year16.1917.411.495.091,471,001-14.16-87.46%
3 Years21.0536.351.4913.511,007,062-19.02-90.36%
5 Years43.9044.991.4918.28840,243-41.87-95.38%

Acorda Therapeutics Description

Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders.Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.

Your Recent History
Acorda The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.